BiopharmaTrend.com

BenevolentAI

BenevolentAI

Private company
BENEVOLENTAI

BenevolentAI uses artificial intelligence to mine and analyse biomedical information, from clinical trails data to academic papers.

Benevolent AI can also use the predictive power of its AI algorithm to design new molecules, extracting new hypothesis based on a knowledge graph composed of over a billion relationships between genes, targets, diseases, proteins and drugs. “When the periodic table of the elements was generated, there were gaps in that table where you know elements had to exist, but they hadn't been discovered,” Hunter says. “We use our knowledge graph like that: what relationship should be present but are not yet known?"


Founded
2013
Status
Private company
Geography
United Kingdom based
Funding
$292 M
Patents
22
Research papers
16
Clinical Trials
1

Products

The Benevolent Platform

Built on powerful data foundations and state of the art technology, the Benevolent Platform® empowers scientists to decipher the vast …

Read more

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page